| 
                        1.
                     | 
                        Seebri Breezhaler
                     | 
                        Inh Kaps 50 mcg 
                     | 
                        30 Stk
                     | 
                        35.38
                     | 
                        54.90
                     | 
                        01.12.2022
                     | 
                                                
                     | 
                        
                     | 
                      
                     | 
                        Nein                        
                     | 
                        62580001
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Glycopyrronium
                     | 
                        20035
                     | 
                        01.09.2013
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                         
                     | 
                        03.04.30.
                     | 
                        R03BB06
                     | 
					
						| 
                        2.
                     | 
                        Seebri Breezhaler
                     | 
                        Inh Kaps 50 mcg 
                     | 
                        3 x 30 Stk
                     | 
                        106.13
                     | 
                        131.85
                     | 
                        01.12.2022
                     | 
                                                
                     | 
                        
                     | 
                      
                     | 
                        Nein                        
                     | 
                        62580002
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Glycopyrronium
                     | 
                        20035
                     | 
                        01.09.2013
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                         
                     | 
                        03.04.30.
                     | 
                        R03BB06
                     |